Highlights a case of severe restrictive mitral regurgitation as an adverse effect of cabergoline therapy.
Cabergoline may be linked to restrictive mitral regurgitation; this case report is hypothesis-generating and does not support practice change.
To the Editor: A 74-year-old man presented with progressive and severe dyspnea of two months' duration. The patient had Parkinson's disease that had initially been treated with levodopa, to which c...
No takes yet. Share an insight, caveat, or question.
Piñero et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: